Platform for hit-to-lead identification of antibacterial lysins developed
A group of scientists has created a novel high-throughput hit-to-lead development platform to identify engineered antibacterial lysins.
List view / Grid view
A group of scientists has created a novel high-throughput hit-to-lead development platform to identify engineered antibacterial lysins.
Engineering antibodies found in a llama, researchers have developed a potential COVID-19 therapy which they say can neutralise SARS-CoV-2.
A new study has created an atlas of human thymus development, to reveal which genes are needed for the production of specific T cells.
15 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers at VIB and Ghent University have discovered an important mechanism of sepsis, an overreaction of the body’s immune system to an infection...
2 February 2015 | By Imec
The CARDIS project will develop and validate an early-stage cardio vascular disease detection platform using integrated silicon photonics...